• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ainos Inc (NQ: AIMD )

    0.4659 +0.0212 (+4.77%)
    Streaming Delayed Price Updated: 3:48 PM EST, Nov 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 27,165
    Open 0.4760
    Bid (Size) 0.4420 (13)
    Ask (Size) 0.4661 (9)
    Prev. Close 0.4447
    Today's Range 0.4300 - 0.4760
    52wk Range 0.4000 - 4.290
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments
    Via ACCESSWIRE
    Ainos Announces IRB Approval for Sjögren’s Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025
    Via ACCESSWIRE

    Performance

    YTD
    -75.73%
    -75.73%
    1 Month
    -17.10%
    -17.10%
    3 Month
    -27.88%
    -27.88%
    6 Month
    -63.02%
    -63.02%
    1 Year
    -84.34%
    -84.34%

    More News

    Read More
    Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities
    Via ACCESSWIRE
    Ainos Reports Third Quarter 2024 Financial Results
    Via ACCESSWIRE
    Ainos Expands Patent Portfolio With Strategic Shareholder’s Cutting-Edge Technology Assets
    Via ACCESSWIRE
    Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast
    Via ACCESSWIRE
    Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren’s Syndrome
    Via ACCESSWIRE
    Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference
    Via ACCESSWIRE
    Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter
    Via ACCESSWIRE
    Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA
    Via ACCESSWIRE
    Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options
    Via ACCESSWIRE
    Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts
    Via ACCESSWIRE
    AIMD Stock Earnings: Ainos Reported Results for Q2 2024
    Via InvestorPlace
    Ainos Concludes Growth Financing From Lind Partners
    Via ACCESSWIRE
    Ainos Reports Second Quarter 2024 Financial Results
    Via ACCESSWIRE
    Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA
    Via ACCESSWIRE
    Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention
    Via ACCESSWIRE
    Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety
    Via ACCESSWIRE
    Why Is Ainos (AIMD) Stock Up 38% Today?
    Via InvestorPlace
    Topics Intellectual Property
    Exposures Intellectual Property
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024
    Via ACCESSWIRE
    Ainos Secures Exclusive Multi-Regions Invention Patent Licenses from Strategic Partner to Bolster AI Nose and Point-Of-Care Testing
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.